Showing results (331-340 of 1,188) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|July 26, 2023
Information fraction estimation: Strategies for a phase 3 non-inferiority maximum duration design with time to event outcomeHa M Dang, Mark D Krailo, Todd A Alonzo, et al.Pharmaceutical Statistics|November 26, 2019
Comparisons of outlier tests for potency bioassaysPerceval Sondag, Lingmin Zeng, Binbing Yu, et al.Pharmaceutical Statistics|February 20, 2020
Restricted mean survival time as a summary measure of time-to-event outcomeTakahiro Hasegawa, Saori Misawa, Shintaro Nakagawa, et al.Pharmaceutical Statistics|January 14, 2020
Study design of single-arm phase II immunotherapy trials with long-term survivors and random delayed treatment effectChenghao Chu, Shufang Liu, Alan RongPharmaceutical Statistics|November 4, 2020
Assessment of the information theory approach to evaluating time-to-event surrogate and true endpoints in a meta-analytic settingNatalie Dimier, Susan ToddPharmaceutical Statistics|January 29, 2020
A novel quantification of information for longitudinal data analyzed by mixed-effects modelingMin Yuan, Yi Li, Yaning Yang, et al.Pharmaceutical Statistics|September 10, 2020
Sample size calculation for logrank test and prediction of number of events over timeKaifeng LuPharmaceutical Statistics|October 7, 2020
The current state of Bayesian methods in nonclinical pharmaceutical statistics: Survey results and recommendations from the DIA/ASA-BIOP Nonclinical Bayesian Working GroupPaul Faya, Perceval Sondag, Steven Novick, et al.Pharmaceutical Statistics|January 8, 2020
Applications of Bayesian analysis to proof-of-concept trial planning and decision makingHui Quan, Xun Chen, Yu Lan, et al.Pharmaceutical Statistics|January 29, 2019
Tests for noninferiority trials with binomial endpoints: A guide to modern and quasi-exact methods for biomedical researchersEnrico Ripamonti, Chris J LloydPageof 119